Neuroprosthetics Market By Type | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Neuroprosthetics Market
Neuroprosthetics Market: By Type (Motor Neuroprosthetics, Auditory Neuroprosthetics/ Cochlear implants, Visual Neuroprosthetics/ Retinal implants, Cognitive Neuroprosthetics) & By Geography-Forecast (2016-2021)
Report Code : HCR 0346
Updated Date: 08 March, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Neuroprosthetics– Market Overview
2. Executive Summary 
3. Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Neuroprosthetics– Market Forces
   4.1. Drivers
      4.1.1. Rising demand for Oxygen Therapy Device sin the developing nations
   4.2. Restrains
      4.2.1. Rapidly ageing population with increasing risk of developing cancer 
   4.3. Opportunity
      4.3.1 Emerging Economies
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Neuroprosthetics– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis 
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Neuroprosthetics Market, By Drug class
   6.1. Motor Neuroprosthetics
   6.2. Auditory Neuroprosthetics/ Cochlear implants
   6.3. Visual Neuroprosthetics/ Retinal implants
   6.4. Cognitive Neuroprosthetics 
   6.5. Others
7. Neuroprosthetics Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America 
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Neuroprosthetics– Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   9.1. Cochlear Limited
   9.2. Cyberonics Inc
   9.3. Medtronic Inc
   9.4. NDI Medical LLC
   9.5. NeuroPace, Inc. 
   9.6. Boston Scientific Corporation
   9.7. St. Jude Medical, Inc
   9.8. Retina Implant AG
   9.9. Nervo Corp
   9.10. MED-EL
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of expert Insights
   10.6. Disclaimer
Neuroprosthetics, also known as brain implants or neural implants, have added significant momentum in the past few years due to the massive potential to substitute any injured motor, sensory or cognitive functions. Globally, Development of efficient and advance technology and Rising demand for Oxygen Therapy Device sin the developing nations are the prime growth drivers of global Neuroprosthesis market. In addition, emerging economies such as China, India and others, will create new opportunities for global Neuroprosthetics market. However, higher cost of the research and development and ageing population with increasing risk of developing cancer is the key restraints for global Neuroprosthetics market.
       
 Neuroprosthetics Market

North America held the largest revenue accounted for 50.0% of overall market share. The large share is attributed to the presence of factors, such as government &private funding and well-established healthcare facilities. In the European market, neuroprosthetics is expected to show an upward shift owing to the increasing government initiatives pertaining to the development of technologically advanced devices for individuals with a hearing impairment, which offer fast and speedy growth. Asia pacific is expected to be the fastest growing region due to the presence of untapped opportunities in the emerging economies.

This report identifies the Neuroprosthetics market size in for the year 2016-2021, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to Neuroprosthetics market.

This report segments global Neuroprosthetics market on the basis of drug classes,  and regional market as follows:


  • This report is segmented into drug classes. Such as, Motor Neuroprosthetics, Auditory Neuroprosthetics/ Cochlear implants, Visual Neuroprosthetics/ Retinal implants, Cognitive Neuroprosthetics,  and Others
  • This report has been further segmented into major regions, which include detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region. The major countries considered under the Asia-Pacific region are India, China, South Korea and Japan. The major countries considered under the European region are Germany, U.K., France, Italy, Spain and Russia. The major countries considered under the North American region are United States, Canada and Mexico

This report identifies all the major companies operating in the global Neuroprosthetics market. Some of the major companies’ profiles in detail are as follows:
  • Cochlear Limited
  • Cyberonics Inc
  • Medtronic Inc
  • NDI Medical LLC
  • NeuroPace, Inc.
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll